AI Article Synopsis

  • Respiratory issues in primary antiphospholipid syndrome (PAPS) often stem from blood clots, but hemorrhagic alveolitis is a serious complication that can also arise.
  • A case is presented involving a 63-year-old man with a history of blood clots who developed life-threatening hemorrhagic alveolitis and was treated with medications including cyclophosphamide and steroids.
  • The patient's condition recurred, revealing a positive lupus anticoagulant test and severe low platelet counts, leading to further complications like adrenal infarction and requiring extensive medical treatment.

Article Abstract

Pulmonary involvement in the primary antiphospholipid syndrome (PAPS) has generally been on the basis of thromboembolism. We describe a patient with hemorrhagic alveolitis, a life-threatening complication that must also be considered. The patient was a 63-year-old Caucasian man who had a past history of recurrent deep vein thromboses as well as an arterial occlusion of the left popliteal artery and who developed hemorrhagic alveolitis and capillaritis at age 57 years, which was treated with long-term cyclophosphamide, steroids, and anticoagulation. Four years later, he had a recurrence of the same condition, and a positive lupus anticoagulant test was found. Severe thrombocytopenia, diagnosed as idiopathic thrombocytopenic purpura, was treated with platelet transfusions and increasing steroid dosage. Hemorrhagic adrenal infarction supervened at this time, and a septicemic illness was treated with intravenous antibiotics. Diffuse alveolar pulmonary hemorrhage is an unusual complication of the APS that is being increasingly reported, and recognition of its possible fatal course is of great importance for the treating physician. Severe thrombocytopenia that could contribute to hemorrhage may also accompany the APS, but this is unusual.

Download full-text PDF

Source
http://dx.doi.org/10.1097/00124743-200102000-00007DOI Listing

Publication Analysis

Top Keywords

antiphospholipid syndrome
8
hemorrhagic alveolitis
8
severe thrombocytopenia
8
recurrent alveolar
4
alveolar hemorrhage
4
hemorrhage pulmonary
4
pulmonary capillaritis
4
capillaritis "primary"
4
"primary" antiphospholipid
4
syndrome pulmonary
4

Similar Publications

Systemic lupus erythematosus (SLE) is a chronic autoimmune disease with a complex etiology primarily linked to abnormalities in B lymphocytes within the human body, resulting in the production of numerous pathogenic autoantibodies. Telitacicept is a relatively novel humanized, recombinant transmembrane activator, calcium modulator and cyclophilin ligand interactor fused with the Fc portion (TACI-Fc). It works by competitively inhibiting the TACI site, neutralizing the activity of B-cell lymphocyte stimulator and A proliferation-inducing ligand.

View Article and Find Full Text PDF

Chronic subdural hematoma is a common condition in neurosurgical practice. It is usually treated by burr-hole surgery. Patients with coagulopathies such as antiphospholipid syndrome, are at increased risk of complications, and careful consideration of the patient's specific risk of both bleeding and thromboembolic complications must guide medical management.

View Article and Find Full Text PDF

Impact of Lupus Anticoagulant on INR Using Recombinant Prothrombin Time Reagent.

Am J Case Rep

January 2025

Department of Clinical Diagnostic Laboratories, Hospital Al-Sultan Abdullah, Puncak Alam, Selangor, Malaysia.

BACKGROUND Lupus anticoagulants (LA) can interfere with routine coagulation tests such as the activated partial thromboplastin time (aPTT) and prothrombin time (PT). The international normalized ratio (INR) is derived from PT and is used to monitor warfarin therapy. A positive LA result is one of the laboratory criteria of the 2023 ACR/EULAR antiphospholipid syndrome (APS) classification criteria.

View Article and Find Full Text PDF

Introduction: The incidence of cognitive compromise in systemic lupus erythematosus is variable; it presents early and is usually asymptomatic. Our study evaluated the frequency of cognitive impairment in patients without a previous diagnosis of neuropsychiatric lupus and compared the differences in intracerebral size in subgroups with cognitive alterations and positive autoantibodies.

Methods: This is a cross-sectional study.

View Article and Find Full Text PDF

Infective endocarditis causing acute aortic occlusion in a patient with systemic lupus erythematosus: A rare case report.

Int J Surg Case Rep

January 2025

Department of Vascular Surgery, Royal Perth Hospital, Perth 6000, Australia; University of Western Australia, School of Surgery, Perth 6000, Australia. Electronic address:

Introduction: We present a unique case of acute aortic occlusion secondary to infective endocarditis (IE).

Presentation Of Case: An Aboriginal Australian woman with systemic lupus erythematosus presented with fever, confusion, tachycardia, and tachypnoea and had cold, pulseless, insensate, and paralysed lower limbs. Computed tomography angiography revealed multifocal occlusion of the distal aorta and lower limb vessels.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!